AxoSim, Inc. acquired the microBrain™-associated assets of Vyant Bio’s StemoniX subsidiary in October 2023.
The microBrain™ technology provides a physiologically relevant human iPSC-derived screening platform for CNS drug discovery and toxicity testing. The organoid platform replicates important human CNS biology, containing cortical neurons and astrocytes that self-organize and form functional networks in 3D. The hallmark of the microBrain™ organoids is their remarkably consistent performance, making them ideal for high-throughput neurotoxicology, neuromodulation, and drug discovery investigations.
For more information about microBrain™ contact sales@axosim.com
Company Details
- Founded
- -
- Address
- 13300 67th Ave N, Maple Grove,minnesota 55311,united States
- Phone
- (612)804-8225
- in****@****nix.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- stemonix.com
- Keywords
- Human iPS Cells, Stem Cells, Cardiomyocytes, Neurons, Astrocytes, iPS Cell Manufacturing, Drug Discovery, High Throughput Screening, in vitro Assay Development, Disease Modeling, Hazard Identification.
- HQ
- Maple Grove, Minnesota
Stemonix, Acquired By Axosim Questions
Stemonix, Acquired By Axosim's helpline number is (612)804-8225
Stemonix, Acquired By Axosim's website is stemonix.com
Stemonix, Acquired By Axosim's LinkedIn profile is https://www.linkedin.com/company/stemonix
Stemonix, Acquired By Axosim's industry is
Biotechnology Research
Stemonix, Acquired By Axosim's top competitors are
Cancer Genetics, Inc.,
Stem Pharm,
Simatomic,
Vascular Solutions - Now Part Of Teleflex,
Vyant Bio,
Reprise Biomedical,
Brainstorm Therapeutics, Inc.,
Axosim,
Vascudyne Inc,
Recursion.
Stemonix, Acquired By Axosim's support email address is info@stemonix.com
Stemonix, Acquired By Axosim's categories are Biotechnology Research
Stemonix, Acquired By Axosim's founding year is 2014
